Show
Sort by
-
Ipilimumab-induced enterocolitis : description of histopathological observations in 6 cases and selected literature review
-
Characterization of the in vivo immune network of IDO, tryptophan metabolism, PD-L1, and CTLA-4 in circulating immune cells in melanoma
-
Small bowel metastases from melanoma : does videocapsule provide additional information after FDG positron emission tomography?
-
An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy
-
Cetuximab with hepatic arterial infusion of chemotherapy for the treatment of colorectal cancer liver metastases
-
Techniques for the placement of hepatic artery catheters for regional chemotherapy in unresectable liver metastases
-
A phase III randomized controlled trial of panitumumab in patients with metastatic colorectal cancer: subset analyses in elderly patients and in patients with poor performance status.
-
Association of skin toxicity (ST) severity with clinical outcomes and health-related quality of life (HRQoL) with panitumumab (Pmab)
-
Patient-reported outcome (PRO)-assessed clinical benefit with panitumumab (Pmab) in metastatic colorectal cancer (mCRC) patients (pts)
-
Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer